A carregar...
Transcriptional upregulation of c‐MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma
AXL receptor tyrosine kinase is overexpressed in esophageal adenocarcinoma (EAC) and several other types of malignancies; hence, it may be a valuable therapeutic target. Herein, we investigated the role of AXL in regulating c‐MYC expression and resistance to the chemotherapeutic agent epirubicin in...
Na minha lista:
| Publicado no: | Mol Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6275285/ https://ncbi.nlm.nih.gov/pubmed/30353671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12395 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|